|
EP3276006A1
|
|
Lentiviral vectors for expression of hepatitis b virus (hbv) antigens
|
|
WO2016120489A2
|
|
Lentiviral vectors for expression of mycobacterium tuberculosis antigens
|
|
WO2016120492A1
|
|
Lentiviral vectors for expression of hepatitis b virus (hbv) antigens
|
|
EP3511413A1
|
|
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
|
|
WO2015111024A1
|
|
Lentiviral vectors for generating immune responses against human t lymphotrophic virus type 1
|
|
WO2015097650A1
|
|
Lyophilized lentiviral vector particles, compositions and methods
|
|
WO2015063708A1
|
|
LENTIVIRAL VECTORS FOR INDUCING CD4+ and CD8+ IMMUNE RESPONSES IN VACCINATION OF HUMANS INFECTED WITH HIV-1
|
|
EP3009144A1
|
|
Lentiviral vectors for inducing CD4+ and CD8+ immune responses in vaccination of humans
|
|
AU2014277092A1
|
|
Lentiviral vectors containing an MHC class I, MHC class II, or beta-2 microglobulin upstream promoter sequence
|
|
WO2014016383A2
|
|
Glycoproteins for pseudotyping lentivectors
|
|
CA2849652A1
|
|
Use of non-subtype b gag proteins for lentiviral packaging
|
|
EP2666477A1
|
|
Lentiviral vectors containing an MHC class I promoter
|
